Why OnQ Prostate Is Different from Other Prostate Imaging Technologies
Why OnQ Prostate Is Different from Other Prostate Imaging Technologies
Want to see more?
< 1 mins
10/13/2026
NeuroQuant PET Is Now FDA Cleared
NeuroQuant PET is now FDA cleared, with centiloid estimation for amyloid PET and support for all FDA-approved dementia tracers.
< 1 mins
10/13/2026
Know Where Your Patient Started: Centiloids in the Era of Anti-Amyloid Therapy
Neuroradiologist Dr. Suzie Bash explains why baseline centiloid values from amyloid PET are key to anti-amyloid maintenance dosing decisions.
< 1 mins
10/01/2026
Comprehensive Insights on Metastatic Melanoma with NeuroQuant® CT | Dr. Niky Farid
By bringing key imaging findings together into a single structured report, NeuroQuant CT helps radiologists and clinicians quickly review critical information.
< 1 mins
10/01/2026
Transforming Prostate Cancer Care with OnQ™ Prostate
OnQ Prostate adds color-coded imaging insights that help clinicians more clearly visualize regions.
< 1 mins
10/01/2026
Why Urologists Choose OnQ™ Prostate for Better Lesion Detection
OnQ Prostate is helping clinicians gain deeper insights from prostate MRI using advanced diffusion modeling.
< 1 mins
10/01/2026
Transforming Brain Imaging with NeuroQuant® CT & NeuroQuant® Brain Tumor | Dr. Niky Farid
Hear from Dr. Niky Farid as she shares her experience using NeuroQuant® CT and NeuroQuant® Brain Tumor.
